跳至主要内容
临床试验/NCT00785733
NCT00785733已完成不适用

SMART Way of Treating Asthma. Non-interventional Study to Evaluate Clinical Efficacy of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Patients With Moderate and Severe Asthma

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,182 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,182
试验地点
1
主要终点
Asthma Control Questionnaire ACQ

研究概览

简要总结

The primary objective of this non-interventional study is to evaluate efficacy of Symbicort® SMART treatment in adult patients with moderate to severe asthma using ACQ scores during 6 months period

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients eligible for entry into study are the patients diagnosed with moderate to severe asthma, that the doctors have already decided to treat with Symbicort SMART within the last month, before inclusion in this program
  • All eligible patients will be included in the protocol provided they will receive detailed information in advance and will sign consent to grant access to their own data collected during this programme.

排除标准

  • All the patients who have a known hypersensitivity to Symbicort or any of its excipients will not be included in this study.
  • As per valid Romanian SmPC, concomitant medication, that could result in drug interactions and could jeopardise patient safety will be carefully considered before having the patient enrolled.

结局指标

主要结局

Asthma Control Questionnaire ACQ

时间窗: 5 visits (V1-week 0, V2-week 4, V3-week 8, V4-week 16, V5-week 24)

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

NIS-observe Treatment Efficacy in Maintaining... | 临床试验